FDA
approval
· 2022-02-28
FDA Approved: LOW-OGESTREL — Supplemental Application (Mayne Pharma Inc.)
Summary
The FDA approved a supplemental application for Low-Ogestrel, a combined oral contraceptive containing norgestrel and ethinyl estradiol, from Mayne Pharma, auth…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LOW-OGESTREL (NORGESTREL AND ETHINYL ESTRADIOL)